Is Progressive Supranuclear Palsy (PSP) Hereditary?
At a Glance
Progressive Supranuclear Palsy (PSP) is rarely hereditary and is usually not passed down to children. While genetic risk factors like the MAPT H1 haplotype exist, they do not directly cause the disease, and routine genetic testing is not recommended.
In this answer
3 sections
No, for the vast majority of people, Progressive Supranuclear Palsy (PSP) is not hereditary. Having PSP does not mean your children will definitely inherit the disease. PSP is almost always considered a sporadic disorder [1][2], meaning it occurs randomly without a clear family link.
Understanding the MAPT H1 Haplotype
Many families reading about PSP will see mentions of genetics, particularly something called the MAPT H1 haplotype. When navigating these terms, it is important to understand the difference between a “risk factor” and a “direct cause.”
The MAPT gene provides instructions for making tau, a protein that builds up abnormally in the brains of people with PSP [3]. (While the tau protein is also involved in Alzheimer’s disease, the way genetic risks affect the cells in PSP is entirely different from Alzheimer’s [3]). The H1 haplotype is a specific, normal variation of the MAPT gene.
- It is a risk factor: Research shows that the MAPT H1 haplotype is strongly associated with an increased susceptibility to developing PSP [4][5]. In fact, the vast majority of people with PSP have this genetic trait.
- It is NOT a diagnosis: This same genetic variation is incredibly common in the general, healthy population. Millions of people have the MAPT H1 haplotype and will never develop PSP or any other neurological disease. Having this variant might slightly increase the risk, but it is not enough on its own to cause the disease.
Other Genetic Markers
Scientists have identified other minor genetic variations in genes like MOBP and STX6 that might also influence a person’s risk of developing PSP [6][7]. Like the MAPT H1 haplotype, these are just pieces of a complex puzzle, likely requiring a combination of genetics, aging, and environmental factors to trigger the disease. Currently, the specific environmental triggers for PSP remain unknown.
When is PSP Hereditary?
True familial (inherited) PSP is extremely rare. When it does run in families, it is usually linked to specific, rare mutations in the MAPT gene [8] — which are completely different from the common H1 haplotype risk factor. These rare inherited mutations typically cause a broader range of symptoms, often overlapping with conditions like frontotemporal dementia [9].
If you do not have multiple family members who were diagnosed with similar neurological conditions, the likelihood of a hereditary form of PSP is minimal. However, if you do have a strong family history of neurodegenerative disease, you should consult a genetic counselor or a neurogeneticist.
Should my family get genetic testing?
Because PSP is primarily sporadic, routine genetic testing for family members is generally not recommended. Commercial genetic testing for the MAPT H1 haplotype is not useful because finding out you have the variant cannot tell you if you will actually develop the disease. If you are concerned about your specific family history, the best first step is to discuss it with your neurologist to completely rule out the rare familial type.
Common questions in this guide
Is Progressive Supranuclear Palsy passed down in families?
Will my children inherit PSP if I have it?
What is the MAPT H1 haplotype in PSP?
Should my family get genetic testing for PSP?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my specific family history, is there any reason to suspect a rare, inherited form of PSP?
- 2.Do you recommend that I consult with a genetic counselor or a neurogeneticist?
- 3.Are there clinical trials studying genetic markers for PSP that I might be eligible to participate in?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (9)
- 1
Genetics of Progressive Supranuclear Palsy.
Im SY, Kim YE, Kim YJ
Journal of movement disorders 2015; (8(3)):122-9 doi:10.14802/jmd.15033.
PMID: 26413239 - 2
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Respondek G, Kurz C, Arzberger T, et al.
Movement disorders : official journal of the Movement Disorder Society 2017; (32(7)):995-1005 doi:10.1002/mds.27034.
PMID: 28500752 - 3
Cross-disorder and disease-specific pathways in dementia revealed by single-cell genomics.
Rexach JE, Cheng Y, Chen L, et al.
Cell 2024; (187(20)):5753-5774.e28 doi:10.1016/j.cell.2024.08.019.
PMID: 39265576 - 4
MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.
Pastor P, Moreno F, Clarimón J, et al.
Journal of Alzheimer's disease : JAD 2016; (49(2)):343-52 doi:10.3233/JAD-150555.
PMID: 26444794 - 5
Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
Heckman MG, Brennan RR, Labbé C, et al.
JAMA neurology 2019; (76(6)):710-717 doi:10.1001/jamaneurol.2019.0250.
PMID: 30882841 - 6
Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes.
Farrell K, Humphrey J, Chang T, et al.
Nature communications 2024; (15(1)):7880 doi:10.1038/s41467-024-52025-x.
PMID: 39251599 - 7
Functional regulatory variants implicate distinct transcriptional networks in dementia.
Cooper YA, Teyssier N, Dräger NM, et al.
Science (New York, N.Y.) 2022; (377(6608)):eabi8654 doi:10.1126/science.abi8654.
PMID: 35981026 - 8
In Vivo 18 F-APN-1607 Tau Positron Emission Tomography Imaging in MAPT Mutations: Cross-Sectional and Longitudinal Findings.
Zhou XY, Lu JY, Liu FT, et al.
Movement disorders : official journal of the Movement Disorder Society 2022; (37(3)):525-534 doi:10.1002/mds.28867.
PMID: 34842301 - 9
Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories.
Tacik P, Sanchez-Contreras M, Rademakers R, et al.
Neuro-degenerative diseases 2016; (16(1-2)):12-21 doi:10.1159/000440840.
PMID: 26550830
This page provides educational information about the genetics of Progressive Supranuclear Palsy (PSP). It does not replace professional medical advice or personalized genetic counseling from a neurologist or neurogeneticist.
Get notified when new evidence is published on Progressive supranuclear palsy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.